Thursday, December 08, 2016
 
 
Video: Page (1) of 1 - 05/11/12 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
GlaxoSmithKline Issues Hostile Bid for Human Genome

By DMO Affiliate
GlaxoSmithKline (NYSE:GSK) is going hostile after announcing a $13 a share cash tender offer for Human Genome Sciences.The drug maker had offered to buy Human Genome for $2.6 billion last month, that was rejected by Human's board. Human Genome's reason wa
GlaxoSmithKline Issues Hostile Bid for Human Genome




Page: 1


null
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines